CellWell record HH-3083
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation
Duran CG, Burbank AJ, Mills KH, Duckworth HR, Aleman MM, Kesic MJ, Peden DB, Hernandez ML
Respiratory Research ยท 2016
In plain language
In this human ozone-challenge study, oral sulforaphane from broccoli sprout homogenate did not measurably increase antioxidant gene expression or protect against airway inflammation, a useful null finding on dosing and context.
- Design
- Randomized controlled trial
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-3083
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.